Ann-Christine Nyquist
Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Influenza, Human | 13 | 2024 | 566 | 2.150 |
Why?
| Respiratory Tract Infections | 8 | 2021 | 335 | 1.270 |
Why?
| Cross Infection | 7 | 2020 | 218 | 1.040 |
Why?
| Infection Control | 4 | 2023 | 138 | 0.840 |
Why?
| Surgical Wound Infection | 6 | 2023 | 251 | 0.820 |
Why?
| Health Personnel | 9 | 2022 | 603 | 0.730 |
Why?
| Bacteremia | 6 | 2019 | 169 | 0.560 |
Why?
| Virus Diseases | 2 | 2016 | 201 | 0.540 |
Why?
| Influenza Vaccines | 4 | 2024 | 504 | 0.530 |
Why?
| Respiratory Protective Devices | 3 | 2021 | 14 | 0.520 |
Why?
| Disease Outbreaks | 6 | 2020 | 333 | 0.450 |
Why?
| Population Surveillance | 4 | 2020 | 439 | 0.440 |
Why?
| Disaster Planning | 3 | 2020 | 77 | 0.420 |
Why?
| Hospitals, Pediatric | 5 | 2019 | 507 | 0.410 |
Why?
| Vaccination | 6 | 2024 | 1241 | 0.400 |
Why?
| Influenza B virus | 2 | 2009 | 33 | 0.400 |
Why?
| Influenza A virus | 3 | 2014 | 112 | 0.400 |
Why?
| Chemical Terrorism | 2 | 2020 | 4 | 0.370 |
Why?
| Bioterrorism | 2 | 2020 | 20 | 0.370 |
Why?
| Masks | 3 | 2021 | 51 | 0.350 |
Why?
| Disease Notification | 1 | 2009 | 16 | 0.350 |
Why?
| Anti-Bacterial Agents | 4 | 2020 | 1562 | 0.350 |
Why?
| Health Care Surveys | 1 | 2010 | 564 | 0.320 |
Why?
| Equipment Contamination | 3 | 2019 | 56 | 0.300 |
Why?
| Mycoplasma hominis | 1 | 2006 | 4 | 0.290 |
Why?
| Delivery of Health Care | 9 | 2022 | 915 | 0.290 |
Why?
| Endocarditis, Bacterial | 1 | 2006 | 38 | 0.280 |
Why?
| Medication Systems, Hospital | 1 | 2005 | 8 | 0.280 |
Why?
| Enterovirus Infections | 3 | 2015 | 165 | 0.280 |
Why?
| Forms and Records Control | 1 | 2005 | 23 | 0.280 |
Why?
| Drug Utilization Review | 1 | 2005 | 65 | 0.270 |
Why?
| Electronics | 1 | 2005 | 79 | 0.270 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 101 | 0.250 |
Why?
| Pandemics | 2 | 2022 | 1401 | 0.230 |
Why?
| Humans | 45 | 2024 | 122796 | 0.230 |
Why?
| Surgical Procedures, Operative | 1 | 2005 | 227 | 0.230 |
Why?
| Seasons | 5 | 2024 | 468 | 0.220 |
Why?
| Child | 18 | 2022 | 19561 | 0.210 |
Why?
| Coronavirus OC43, Human | 1 | 2021 | 5 | 0.210 |
Why?
| Tuberculosis, Spinal | 1 | 2001 | 6 | 0.210 |
Why?
| Personal Protective Equipment | 1 | 2022 | 56 | 0.210 |
Why?
| Orthomyxoviridae Infections | 1 | 2022 | 60 | 0.200 |
Why?
| Thoracic Vertebrae | 1 | 2001 | 73 | 0.200 |
Why?
| Meningitis, Viral | 2 | 2011 | 21 | 0.200 |
Why?
| Virology | 2 | 2011 | 20 | 0.200 |
Why?
| Hospitalization | 2 | 2015 | 1914 | 0.200 |
Why?
| Physician's Role | 2 | 2020 | 207 | 0.200 |
Why?
| Guideline Adherence | 1 | 2005 | 560 | 0.200 |
Why?
| Colorado | 8 | 2020 | 4325 | 0.190 |
Why?
| Streptococcus pneumoniae | 3 | 2010 | 144 | 0.190 |
Why?
| Enterovirus | 2 | 2011 | 72 | 0.190 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 147 | 0.190 |
Why?
| Clostridium Infections | 1 | 2020 | 61 | 0.180 |
Why?
| Civil Defense | 1 | 2020 | 21 | 0.180 |
Why?
| Practice Patterns, Physicians' | 2 | 1999 | 1267 | 0.180 |
Why?
| Serratia Infections | 1 | 2019 | 6 | 0.180 |
Why?
| Viruses | 1 | 2021 | 98 | 0.180 |
Why?
| Serratia marcescens | 1 | 2019 | 12 | 0.180 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 22 | 0.180 |
Why?
| Heart Defects, Congenital | 1 | 2006 | 721 | 0.180 |
Why?
| Syringes | 1 | 2019 | 40 | 0.170 |
Why?
| Rotavirus Infections | 1 | 1999 | 55 | 0.170 |
Why?
| Child, Preschool | 11 | 2019 | 9755 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1003 | 0.170 |
Why?
| Antimicrobial Stewardship | 1 | 2020 | 95 | 0.170 |
Why?
| Pediatricians | 1 | 2020 | 121 | 0.160 |
Why?
| Common Cold | 1 | 1998 | 12 | 0.160 |
Why?
| Mandatory Programs | 1 | 2018 | 17 | 0.160 |
Why?
| Communicable Diseases | 1 | 2020 | 135 | 0.160 |
Why?
| Bronchitis | 1 | 1998 | 46 | 0.160 |
Why?
| Electronic Health Records | 2 | 2018 | 842 | 0.160 |
Why?
| United States | 13 | 2023 | 13272 | 0.150 |
Why?
| Hospitals | 3 | 2023 | 633 | 0.150 |
Why?
| Drug Utilization | 1 | 1998 | 183 | 0.150 |
Why?
| Mutation | 1 | 2007 | 3493 | 0.140 |
Why?
| Fatigue | 1 | 2018 | 311 | 0.140 |
Why?
| Catheter-Related Infections | 1 | 2016 | 61 | 0.140 |
Why?
| Infant, Newborn | 5 | 2015 | 5430 | 0.140 |
Why?
| Spinal Fusion | 2 | 2013 | 226 | 0.130 |
Why?
| Occupational Diseases | 1 | 2016 | 143 | 0.120 |
Why?
| Laryngeal Diseases | 1 | 1994 | 21 | 0.120 |
Why?
| Herpesvirus 2, Human | 1 | 1994 | 32 | 0.120 |
Why?
| Enterovirus D, Human | 1 | 2015 | 76 | 0.120 |
Why?
| Gram-Positive Bacterial Infections | 2 | 2012 | 70 | 0.120 |
Why?
| Adult | 10 | 2020 | 32385 | 0.120 |
Why?
| Acyclovir | 1 | 1994 | 104 | 0.120 |
Why?
| Herpes Simplex | 1 | 1994 | 94 | 0.120 |
Why?
| Pertussis Vaccine | 1 | 2012 | 21 | 0.110 |
Why?
| Bacillus cereus | 1 | 2012 | 5 | 0.110 |
Why?
| Whooping Cough | 1 | 2012 | 50 | 0.110 |
Why?
| Shock | 1 | 2013 | 96 | 0.110 |
Why?
| Guidelines as Topic | 1 | 2014 | 273 | 0.110 |
Why?
| Adolescent | 9 | 2015 | 18948 | 0.110 |
Why?
| Consensus | 3 | 2024 | 554 | 0.100 |
Why?
| Spinal Diseases | 1 | 2012 | 47 | 0.100 |
Why?
| Age Distribution | 2 | 2010 | 376 | 0.100 |
Why?
| Comorbidity | 1 | 2016 | 1600 | 0.100 |
Why?
| Infant | 8 | 2015 | 8523 | 0.100 |
Why?
| Decision Making | 1 | 2018 | 840 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 362 | 0.100 |
Why?
| Shock, Septic | 1 | 2013 | 213 | 0.100 |
Why?
| Ethics, Clinical | 1 | 2010 | 11 | 0.100 |
Why?
| Female | 17 | 2019 | 63629 | 0.090 |
Why?
| Online Systems | 1 | 2010 | 28 | 0.090 |
Why?
| Health Planning | 1 | 2010 | 50 | 0.090 |
Why?
| Decontamination | 2 | 2020 | 20 | 0.090 |
Why?
| Software | 1 | 2014 | 631 | 0.090 |
Why?
| Male | 15 | 2019 | 59639 | 0.090 |
Why?
| Ethics, Medical | 1 | 2010 | 80 | 0.090 |
Why?
| Young Adult | 5 | 2015 | 11094 | 0.090 |
Why?
| Laboratories, Hospital | 1 | 2009 | 14 | 0.090 |
Why?
| Workload | 1 | 2010 | 132 | 0.090 |
Why?
| Pneumococcal Infections | 1 | 2010 | 99 | 0.090 |
Why?
| Orthopedic Procedures | 1 | 2012 | 221 | 0.090 |
Why?
| Chlamydia Infections | 1 | 2010 | 85 | 0.090 |
Why?
| Gonorrhea | 1 | 2010 | 72 | 0.080 |
Why?
| Poison Control Centers | 2 | 2020 | 102 | 0.080 |
Why?
| Middle Aged | 7 | 2019 | 28563 | 0.080 |
Why?
| Epoprostenol | 1 | 2009 | 141 | 0.080 |
Why?
| Clinical Laboratory Techniques | 1 | 2009 | 93 | 0.080 |
Why?
| Catheterization, Central Venous | 1 | 2009 | 95 | 0.080 |
Why?
| Ambulatory Care Facilities | 1 | 2010 | 244 | 0.080 |
Why?
| Prescriptions | 1 | 2008 | 67 | 0.080 |
Why?
| Genetic Drift | 1 | 2007 | 9 | 0.080 |
Why?
| Ethanol | 1 | 2012 | 584 | 0.080 |
Why?
| Patient Care Team | 1 | 2012 | 520 | 0.080 |
Why?
| Incidence | 4 | 2019 | 2527 | 0.070 |
Why?
| Respiratory System | 1 | 2007 | 144 | 0.070 |
Why?
| Drug Resistance, Microbial | 2 | 1998 | 71 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2009 | 465 | 0.070 |
Why?
| Sexual Behavior | 1 | 2010 | 470 | 0.070 |
Why?
| Medical Audit | 1 | 2005 | 78 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2013 | 1519 | 0.070 |
Why?
| Pneumococcal Vaccines | 1 | 2006 | 141 | 0.070 |
Why?
| Aged, 80 and over | 3 | 2015 | 6845 | 0.060 |
Why?
| Internet | 1 | 2010 | 686 | 0.060 |
Why?
| Risk Factors | 5 | 2021 | 9381 | 0.060 |
Why?
| Delphi Technique | 2 | 2016 | 170 | 0.060 |
Why?
| Ambulatory Care | 2 | 2019 | 497 | 0.060 |
Why?
| Needs Assessment | 2 | 2020 | 345 | 0.060 |
Why?
| Europe | 1 | 2024 | 369 | 0.060 |
Why?
| Logistic Models | 3 | 2010 | 1995 | 0.060 |
Why?
| Attitude of Health Personnel | 1 | 2010 | 1012 | 0.060 |
Why?
| Immunization Programs | 2 | 2018 | 210 | 0.050 |
Why?
| Hemagglutination Inhibition Tests | 1 | 2022 | 38 | 0.050 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2022 | 39 | 0.050 |
Why?
| Surveys and Questionnaires | 2 | 2010 | 4882 | 0.050 |
Why?
| Patient Satisfaction | 2 | 2010 | 632 | 0.050 |
Why?
| Pediatrics | 2 | 2020 | 1009 | 0.050 |
Why?
| Pneumonia | 1 | 2006 | 605 | 0.050 |
Why?
| Multivariate Analysis | 2 | 2010 | 1531 | 0.050 |
Why?
| Aged | 4 | 2015 | 20495 | 0.050 |
Why?
| Nerve Agents | 1 | 2020 | 4 | 0.050 |
Why?
| Ricin | 1 | 2020 | 8 | 0.050 |
Why?
| Containment of Biohazards | 1 | 2020 | 11 | 0.050 |
Why?
| Surge Capacity | 1 | 2020 | 9 | 0.050 |
Why?
| Smallpox | 1 | 2020 | 7 | 0.050 |
Why?
| Government Agencies | 1 | 2020 | 14 | 0.050 |
Why?
| Asphyxia | 1 | 2020 | 23 | 0.050 |
Why?
| Biological Factors | 1 | 2020 | 42 | 0.050 |
Why?
| Government Regulation | 1 | 2020 | 47 | 0.050 |
Why?
| Irritants | 1 | 2020 | 45 | 0.050 |
Why?
| Attitude | 1 | 2021 | 236 | 0.040 |
Why?
| Health Care Costs | 2 | 2013 | 414 | 0.040 |
Why?
| Gait | 1 | 2001 | 264 | 0.040 |
Why?
| Viral Vaccines | 1 | 1999 | 89 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2022 | 551 | 0.040 |
Why?
| Outpatients | 1 | 2021 | 336 | 0.040 |
Why?
| Rhinitis | 1 | 1999 | 117 | 0.040 |
Why?
| Health Services Misuse | 1 | 1998 | 36 | 0.040 |
Why?
| Heparin | 1 | 2019 | 240 | 0.040 |
Why?
| Absenteeism | 1 | 2018 | 38 | 0.040 |
Why?
| Hypertension, Pulmonary | 1 | 2009 | 1900 | 0.040 |
Why?
| Airway Obstruction | 1 | 2020 | 182 | 0.040 |
Why?
| Histocompatibility Antigens Class II | 1 | 1999 | 397 | 0.040 |
Why?
| Research | 1 | 2020 | 432 | 0.040 |
Why?
| Efficiency, Organizational | 1 | 2018 | 131 | 0.040 |
Why?
| Nasopharyngeal Diseases | 1 | 1996 | 4 | 0.040 |
Why?
| Lung Abscess | 1 | 1996 | 7 | 0.040 |
Why?
| Streptococcus pyogenes | 1 | 1996 | 37 | 0.040 |
Why?
| Occupational Exposure | 1 | 2019 | 298 | 0.040 |
Why?
| Illinois | 1 | 2015 | 39 | 0.030 |
Why?
| Missouri | 1 | 2015 | 65 | 0.030 |
Why?
| Environmental Exposure | 1 | 2020 | 427 | 0.030 |
Why?
| Maryland | 1 | 2014 | 39 | 0.030 |
Why?
| Cough | 1 | 2015 | 104 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2015 | 119 | 0.030 |
Why?
| Health Policy | 1 | 2018 | 356 | 0.030 |
Why?
| Foscarnet | 1 | 1994 | 19 | 0.030 |
Why?
| Workplace | 1 | 2016 | 225 | 0.030 |
Why?
| Mental Health | 1 | 2020 | 571 | 0.030 |
Why?
| Dyspnea | 1 | 2015 | 214 | 0.030 |
Why?
| Streptococcal Infections | 1 | 1996 | 143 | 0.030 |
Why?
| Fever | 1 | 2015 | 289 | 0.030 |
Why?
| Program Evaluation | 2 | 2010 | 880 | 0.030 |
Why?
| Prevalence | 2 | 2010 | 2442 | 0.030 |
Why?
| Prospective Studies | 2 | 2016 | 6704 | 0.030 |
Why?
| Public Health Surveillance | 1 | 2013 | 63 | 0.030 |
Why?
| Retrospective Studies | 2 | 2012 | 13433 | 0.030 |
Why?
| Health Surveys | 1 | 2014 | 468 | 0.030 |
Why?
| Product Recalls and Withdrawals | 1 | 2012 | 2 | 0.030 |
Why?
| Molecular Typing | 1 | 2012 | 19 | 0.030 |
Why?
| Algorithms | 1 | 2020 | 1593 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2012 | 4768 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2015 | 596 | 0.020 |
Why?
| Elective Surgical Procedures | 1 | 2012 | 165 | 0.020 |
Why?
| Case-Control Studies | 2 | 2010 | 3296 | 0.020 |
Why?
| Scoliosis | 1 | 2013 | 186 | 0.020 |
Why?
| Critical Care | 1 | 2015 | 563 | 0.020 |
Why?
| Cerebrospinal Fluid | 1 | 2010 | 92 | 0.020 |
Why?
| San Francisco | 1 | 2010 | 56 | 0.020 |
Why?
| Contact Tracing | 1 | 2010 | 27 | 0.020 |
Why?
| Vaccines, Conjugate | 1 | 2010 | 62 | 0.020 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2009 | 39 | 0.020 |
Why?
| Gram-Positive Bacteria | 1 | 2009 | 48 | 0.020 |
Why?
| Primary Health Care | 1 | 2020 | 1625 | 0.020 |
Why?
| Gram-Negative Bacteria | 1 | 2009 | 72 | 0.020 |
Why?
| Lung Diseases | 1 | 1996 | 764 | 0.020 |
Why?
| Sex Distribution | 1 | 2010 | 370 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2013 | 1423 | 0.020 |
Why?
| Catheters, Indwelling | 1 | 2009 | 82 | 0.020 |
Why?
| Reference Values | 1 | 2010 | 789 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2009 | 396 | 0.020 |
Why?
| Sex Factors | 1 | 2013 | 1860 | 0.020 |
Why?
| Risk Reduction Behavior | 1 | 2009 | 205 | 0.020 |
Why?
| Urban Population | 1 | 2010 | 425 | 0.020 |
Why?
| Length of Stay | 1 | 2012 | 1077 | 0.020 |
Why?
| RNA, Viral | 1 | 2010 | 597 | 0.020 |
Why?
| Serotyping | 1 | 2006 | 33 | 0.020 |
Why?
| Age Factors | 1 | 2013 | 3114 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2010 | 1158 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2010 | 1855 | 0.020 |
Why?
| Immunization Schedule | 1 | 2006 | 187 | 0.020 |
Why?
| Asthma | 1 | 2015 | 2130 | 0.010 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 1213 | 0.010 |
Why?
| Time Factors | 1 | 2010 | 6682 | 0.010 |
Why?
| Retropharyngeal Abscess | 1 | 1996 | 4 | 0.010 |
Why?
| Gallium Radioisotopes | 1 | 1996 | 19 | 0.010 |
Why?
| Radionuclide Imaging | 1 | 1996 | 134 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 1996 | 2500 | 0.000 |
Why?
|
|
Nyquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|